BPAC is delighted to announce that BPACNZRx, a new Medtech prescribing module based on the New Zealand Formulary, is now available for Medtech 32 users. Further details are available here. A Medtech Evolution version will also be available soon.

Latest articles

Update on bpacnz

Letter to our valued readers

May 2020

Preventing and managing bronchiectasis in high-risk paediatric populations

Bronchiectasis is a lung disease characterised by bronchial...

May 2020

Clinical Audit: Reviewing the use of antipsychotic medicines in older people

This audit helps health professionals in primary care to identify...

May 2020

Peer group discussion: Cognitive impairment and dementia in older people

The following questions can be used as discussion points for...

May 2020

National report: The use of antipsychotic medicines in older people

The purpose of this report is to provoke thought and discussion...

May 2020

Symptom management in palliative dementia care

Physical symptoms commonly experienced by people with advanced...

April 2020

Understanding the role of palliative care for people with advanced dementia

Advanced dementia is a terminal condition for which palliative...

April 2020

Managing the behavioural and psychological symptoms of dementia

Most people with dementia develop behavioural and psychological...

April 2020

The 2019 Annual Report is now available

The bpacnz Annual Report provides individualised and practice...

April 2020

The influenza immunisation programme is starting early in 2020

This year’s influenza immunisation programme has the earlier...

March 2020

News Update: cilazapril with hydrochlorothiazide will no longer be available in New Zealand

Patients currently prescribed cilazapril + hydrochlorothiazide...

March 2020

Recognising and managing early dementia

Dementia (mate wareware - see below) is a growing healthcare...

February 2020

Age-related cognitive decline: prevention and future planning

Declining cognitive function can be a difficult topic to raise...

February 2020

Peer group discussion: Referral for patients with suspected bowel cancer

The following questions can be used as discussion points for...

February 2020

Referral of patients with features suggestive of bowel cancer: Ministry of Health guidance

Bowel cancer is one of the most common causes of cancer death...

February 2020

Testing for prostate cancer: helping patients to decide

Testing for prostate cancer is a difficult issue as many prostate...

February 2020

Biosimilars: the future of prescribing biological medicines

Biological medicines are an important advancement in the pharmaceutical...

January 2020

Appropriate prescribing of amino acid formula in infants with cows’ milk protein allergy

This audit helps health professionals in primary care identify...

January 2020

Reducing the burden of melanoma in New Zealand Part 1: Prevention and risk assessment

Limiting UV radiation exposure through sun smart behaviour is...

January 2020

Reducing the burden of melanoma in New Zealand Part 2: Early detection of melanoma

Identification of melanoma at the earliest possible clinical...

January 2020

Peer group discussion: diagnosing and managing perinatal depression in primary care

The following questions can be used as discussion points for...

December 2019

Menopausal hormone therapy: where are we now?

Menopausal hormone therapy (MHT) is an effective treatment for...

December 2019

National report: Prescribing menopausal hormone therapy

Menopausal hormone therapy (MHT) is the most effective treatment...

December 2019

Diagnosing and managing primary ovarian insufficiency

Primary ovarian insufficiency is the loss of ovarian function...

December 2019

Clinical Audit: Reviewing the use of menopausal hormone therapy

This audit helps health professionals in primary care identify...

December 2019

Investigating and managing abnormal vaginal bleeding: an overview

Abnormal vaginal bleeding has many potential causes, ranging...

December 2019

Managing cows' milk protein allergy in infants

Dietary avoidance of cows’ milk is the only management strategy...

November 2019

Diagnosing and managing perinatal depression in primary care

The consequences of perinatal depression* can be severe. Suicide...

November 2019

News update: Criteria widened for exceptional circumstances funding of lamotrigine

November 2019

News update: Annual Prescribing report

November 2019

The role of the primary healthcare team in pregnancy care

Pregnancy is a time when women are likely to engage with a number...

November 2019

Community pharmacy guide on medicine safety in pregnancy

Community pharmacists are a key point of contact for women seeking...

November 2019

News item: access to levonorgestrel intrauterine devices/systems widened

From 1 November, 2019, levonorgestrel intrauterine devices (IUDs;...

October 2019

Reviewing SSRI use in older patients

This audit helps health professionals in primary care identify...

October 2019

Peer group discussion: SSRI prescribing in primary care

The following questions can be used as discussion points for...

October 2019

General Practice papers at the University of Otago

Three new distance taught GENA papers are now available for...

October 2019

Somatisation: demystifying the “ghost in the machine”

Somatisation is a maladaptive functioning of an organ system,...

October 2019

Carbon monoxide poisoning: a hidden danger

Carbon monoxide is an odourless, colourless and tasteless gas....

October 2019

Depression or distress? Examining SSRI prescribing in primary care

Differentiating short-term psychological distress from depression...

October 2019

Motivational interviewing in primary care

Motivational Interviewing is a way of building and strengthening...

September 2019

The nocebo effect: what is it, why is it important and how can it be reduced?

The nocebo effect describes adverse symptoms induced independently...

August 2019

The funded brand of lamotrigine is changing

Changes in funded brands of antiepileptic medicines can lead...

August 2019

Navigating uncertainty: managing respiratory tract infections

With winter upon us, it is timely to reflect on antibiotic prescribing...

August 2019

National report: A pharmacological profile of patients with type 2 diabetes

This report provides an overview of the clinical characteristics...

August 2019

Prescribing report: A pharmacological profile of patients with type 2 diabetes

This report provides an overview of the clinical characteristics...

August 2019

Clinical Audit: Monitoring renal function in patients with diabetes

This audit identifies patients with type 1 and type 2 diabetes...

July 2019

Diabetes theme: Knowing your patients with type 1 diabetes

The following question can be used as discussion points for...

July 2019

Antiarrhythmic medicine brand changes: flecainide and amiodarone

Patients taking oral flecainide or amiodarone need to know that...

July 2019

Knowing your patient with type 1 diabetes: the transition to self-management

Living with type 1 diabetes is challenging, particularly as...

July 2019

Clinical Audit - Encouraging Smoking Cessation

Smoking rates have been steadily declining in New Zealand for...

July 2019

Clinical Audit: Safe and Effective Use of Warfarin

Warfarin is a medicine frequently associated with adverse drug...

July 2019

Clinical Audit: Sexual health checks in younger males

Increasing the uptake of opportunistic testing is essential...

July 2019

Understanding the role of insulin in the management of type 1 diabetes

Insulin treatment is an essential component of type 1 diabetes...

July 2019

Sexual health theme: What’s new in contraception?

The following questions can be used as discussion points for...

June 2019

Slowing progression of renal dysfunction in patients with diabetes

Diabetic kidney disease (DKD) is the leading cause of end-stage...

June 2019

Made with by the bpacnz team